TABLE 5.
Fasting baseline serum metabolites associated with the components used to score the HEI-2010 (chemically identified metabolites; Bonferroni correction and r > |0.15|) in men in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study1
| HEI-2010 components and metabolites | Superpathway | Subpathway | r | P2 |
| Total vegetables | ||||
| Ergothioneine | Xenobiotics | Food component or plant | 0.19 | 7.09 × 10−12 |
| Oxalate (ethanedioate) | Carb; C/V | Glyoxylate/dicarboxylate; ascorbate/aldarate | 0.16 | 1.62 × 10−7 |
| N-δ-acetylornithine | Amino acid | Urea cycle; arginine/proline | 0.15 | 2.60 × 10−8 |
| Threonate | C/V | Ascorbate/aldarate | 0.15 | 8.98 × 10−8 |
| Total fruit | ||||
| Methyl-β-glucopyranoside | Carb | Fructose, mannose, galactose, starch, sucrose | 0.26 | 4.27 × 10−10 |
| Oxalate (ethanedioate) | Carb; C/V | Glyoxylate/dicarboxylate; ascorbate/aldarate | 0.24 | 7.44 × 10−15 |
| Scyllo-inositol | Lipid | Inositol | 0.22 | 2.46 × 10−7 |
| Stachydrine | Xenobiotics | Food component or plant | 0.22 | 3.33 × 10−16 |
| Threonate | C/V | Ascorbate/aldarate | 0.22 | 7.77 × 10−16 |
| Glycerate | Carb | Glycolysis, gluconeogenesis, pyruvate | 0.19 | 5.48 × 10−12 |
| N-methylproline or N-methyl proline | Amino acid | Urea cycle; arginine/proline | 0.18 | 9.74 × 10−10 |
| Threitol | Carb | Pentose | 0.17 | 1.13 × 10−9 |
| Xylonate | Carb | Pentose | 0.17 | 2.00 × 10−9 |
| Ascorbate (vitamin C) | C/V | Ascorbate/aldarate | 0.15 | 2.99 × 10−7 |
| Whole fruit | ||||
| Oxalate (ethanedioate) | Carb; C/V | Glyoxylate/dicarboxylate; ascorbate/aldarate | 0.21 | 5.50 × 10−12 |
| Threonate | C/V | Ascorbate/aldarate | 0.20 | 9.05 × 10−13 |
| Stachydrine | Xenobiotics | Food component or plant | 0.19 | 5.35 × 10−12 |
| Threitol | Carb | Pentose | 0.18 | 1.57 × 10−10 |
| Glycerate | Carb | Glycolysis, gluconeogenesis, pyruvate | 0.17 | 1.46 × 10−9 |
| N-methylproline or N-methyl proline | Amino acid | Urea cycle; arginine/proline | 0.16 | 1.50 × 10−7 |
| Xylonate | Carb | Pentose | 0.16 | 3.42 × 10−9 |
| Whole grain | ||||
| Homostachydrine | Xenobiotics | Food component or plant | 0.31 | <1.00 × 10−16 |
| 2-Aminophenol sulfate | Xenobiotics | Chemical | 0.21 | 9.35 × 10−14 |
| Dairy | ||||
| Galactonate | Carb | Fructose, mannose, galactose, starch, sucrose | 0.29 | 4.73 × 10−11 |
| Myristoyl sphingomyelin | Lipid | Sphingolipid | 0.25 | 1.18 × 10−8 |
| 2-Aminoheptanoate or 2-aminoheptanoic acid | Lipid | MCFA; FA, amino | −0.22 | 7.59 × 10−11 |
| cis-4-Decenoyl carnitine | Lipid | Carnitine | −0.19 | 5.18 × 10−12 |
| Ergothioneine | Xenobiotics | Food component or plant | −0.18 | 2.78 × 10−11 |
| Acisoga | Amino acid | Polyamine | −0.17 | 6.46 × 10−10 |
| 3-Carboxy-4-methyl-5-propyl-2-furanpropanoate | Lipid | FA, dicarboxylate | −0.16 | 2.12 × 10−9 |
| Riboflavin (vitamin B-2) | C/V | Riboflavin | 0.16 | 1.49 × 10−8 |
| S-methylcysteine | Amino acid | Cysteine, methionine, sam, taurine | −0.16 | 2.22 × 10−9 |
| Protein foods | ||||
| Ergothioneine | Xenobiotics | Food component or plant | 0.22 | 8.88 × 10−16 |
| N-acetyl-3-methylhistidine | Amino acid | Histidine | 0.17 | 1.41 × 10−9 |
| trans-4-Hydroxyproline | Amino acid | Urea cycle; arginine/proline | 0.17 | 2.34 × 10−10 |
| 3-Methylhistidine | Amino acid | Histidine | 0.17 | 8.13 × 10−10 |
| 3-Carboxy-4-methyl-5-propyl-2-furanpropanoate | Lipid | FA, dicarboxylate | 0.16 | 4.15 × 10−9 |
| DHA (22:6n–3) | Lipid | Essential FA; PUFA (n–3 and n–6) | 0.15 | 9.50 × 10−8 |
| Pyroglutamine | Amino acid | Glutamate | −0.15 | 2.42 × 10−8 |
| Seafood and plant protein foods | ||||
| 3-Carboxy-4-methyl-5-propyl-2-furanpropanoate | Lipid | FA, dicarboxylate | 0.34 | <1.00 × 10−16 |
| Palmitoyl-oleoyl-glycerophosphoglycerol (2) | Lipid | Lysolipid | 0.32 | 1.08 × 10−12 |
| DHA (22:6n–3) | Lipid | Essential FA; PUFA (n–3 and n–6) | 0.30 | <1.00 × 10−16 |
| 1-Docosahexaenoylglycerol (1-monodocosahexaenoin) | Lipid | Monoacylglycerol | 0.30 | 3.78 × 10−11 |
| EPA (20:5n–3) | Lipid | Essential FA; PUFA (n–3 and n–6) | 0.28 | <1.00 × 10−16 |
| Stearidonate (18:4n–3) | Lipid | LCFA; PUFA (n–3 and n–6) | 0.19 | 1.77 × 10−11 |
| Docosapentaenoate (22:5n–3) | Lipid | Essential FA; PUFA (n–3 and n–6) | 0.18 | 2.11 × 10−11 |
| 1-Docosahexaenoylglycerophosphocholine (22:6n–3) | Lipid | Lysolipid | 0.18 | 1.54 × 10−7 |
| N-acetyl-3-methylhistidine | Amino acid | Histidine | 0.16 | 1.34 × 10−8 |
| 3-Methylhistidine | Amino acid | Histidine | 0.16 | 3.22 × 10−9 |
| Creatine | Amino acid | Creatine | 0.15 | 1.38 × 10−7 |
| Ergothioneine | Xenobiotics | Food component or plant | 0.15 | 2.80 × 10−8 |
| Pyroglutamine | Amino acid | Glutamate | −0.15 | 3.53 × 10−8 |
| Ratio of unsaturated to saturated fat | ||||
| cis-4-Decenoyl carnitine | Lipid | Carnitine | 0.41 | <1.00 × 10−16 |
| γ-CEHC | C/V | Tocopherol | 0.38 | <1.00 × 10−16 |
| γ-CEHC glucuronide | C/V | Tocopherol | 0.37 | <1.00 × 10−16 |
| Linoleate (18:2n–6) | Lipid | Essential FA; PUFA (n–3 and n–6) | 0.34 | <1.00 × 10−16 |
| 1-Myristoleoylglycerophosphocholine (14:1) | Lipid | Lysolipid | −0.34 | 9.14 × 10−11 |
| Linoleoylcarnitine | Lipid | Carnitine | 0.32 | 1.09 × 10−12 |
| Phytanate | Xenobiotics | Food component or plant | −0.31 | 2.26 × 10−13 |
| Methyl palmitate (15 or 2) | Lipid | FA, branched | −0.28 | <1.00 × 10−16 |
| γ-Tocopherol | C/V | Tocopherol | 0.27 | <1.00 × 10−16 |
| 1-Linoleoylglycerophosphoinositol | Lipid | Lysolipid | 0.27 | <1.00 × 10−16 |
| Mead acid (20:3n–9) | Lipid | LCFA; PUFA (n–3 and n–6) | −0.26 | 8.51 × 10−10 |
| Myristoyl sphingomyelin | Lipid | Sphingolipid | −0.26 | 4.87 × 10−9 |
| 1-Linoleoylglycerol (1-monolinolein) | Lipid | Monoacylglycerol | 0.24 | <1.00 × 10−16 |
| Linolenate (α or γ 18:3n–3 or 18:3n–6) | Lipid | Essential FA; PUFA (n–3 and n–6) | 0.23 | 1.11 × 10−16 |
| Palmitoyl-linoleoyl-glycerophosphocholine (1) | Lipid | Lysolipid | 0.23 | 1.87 × 10−7 |
| Palmitoyl-linoleoyl-glycerophosphoinositol (1) | Lipid | Lysolipid | 0.23 | 2.17 × 10−7 |
| Pentadecanoate (15:0) | Lipid | LCFA | −0.23 | 1.11 × 10−16 |
| 1-Palmitoleoylglycerophosphoethanolamine | Lipid | Lysolipid | −0.23 | 2.33 × 10−11 |
| 1-Palmitoleoylglycerophosphoinositol | Lipid | Lysolipid | −0.23 | 9.81 × 10−11 |
| Palmitoyl-linoleoyl-glycerophosphocholine (2) | Lipid | Lysolipid | 0.22 | 7.75 × 10−7 |
| 17-Methylstearate | Lipid | FA, branched | −0.22 | 3.33 × 10−15 |
| 1-Pentadecanoylglycerol (1-monopentadecanoin) | Lipid | Monoacylglycerol | −0.21 | 8.92 × 10−8 |
| Caprate (10:0) | Lipid | MCFA | −0.20 | 1.39 × 10−13 |
| γ-Muricholate (hyocholate) | Lipid | Secondary bile acid | 0.20 | 1.61 × 10−8 |
| Myristoleate (14:1n–5) | Lipid | LCFA | −0.20 | 6.57 × 10−13 |
| 13-Methylmyristic acid | Lipid | FA, branched | −0.20 | 6.96 × 10−12 |
| 1-Pentadecanoylglycerophosphocholine (15:0) | Lipid | Lysolipid | −0.20 | 1.99 × 10−8 |
| 3-Hydroxy-2-ethylpropionate | Amino acid | Valine, leucine/isoleucine | −0.20 | 4.53 × 10−13 |
| 10-Undecenoate (11:1n–1) | Lipid | MCFA | −0.19 | 9.28 × 10−12 |
| 2-Linoleoylglycerophosphocholine | Lipid | Lysolipid | 0.19 | 6.28 × 10−8 |
| Dihomo-linoleate (20:2n–6) | Lipid | LCFA; PUFA (n–3 and n–6) | 0.18 | 2.53 × 10−11 |
| Myristate (14:0) | Lipid | LCFA | −0.18 | 1.16 × 10−10 |
| Campesterol | Lipid | Sterol or steroid | 0.17 | 7.91 × 10−10 |
| 10-Nonadecenoate (19:1n–9) | Lipid | LCFA | −0.17 | 2.49 × 10−10 |
| α-CEHC sulfate (X-12435) | C/V | Tocopherol | 0.16 | 6.18 × 10−7 |
| Docosadienoate (22:2n–6) | Lipid | LCFA; PUFA (n–3 and n–6) | 0.16 | 9.88 × 10−9 |
| 1-Linoleoylglycerophosphocholine (18:2n–6) | Lipid | Lysolipid | 0.16 | 1.06 × 10−8 |
| 1-Myristoylglycerol (1-monomyristin) | Lipid | Monoacylglycerol | −0.16 | 7.18 × 10−9 |
| 2-Linoleoylglycerol (2-monolinolein) | Lipid | Monoacylglycerol | 0.16 | 7.09 × 10−9 |
| 10-Heptadecenoate (17:1n–7) | Lipid | LCFA | −0.15 | 7.21 × 10−8 |
| Limit sodium | ||||
| 1-Oleoylglycerophosphoinositol | Lipid | Lysolipid | 0.15 | 2.74 × 10−8 |
| Limit refined grains | ||||
| 4-Androsten-3β,17β-diol disulfate (1) | Lipid | Sterol or steroid | 0.22 | 3.33 × 10−16 |
| 1-Palmitoleoylglycerophosphoinositol | Lipid | Lysolipid | 0.19 | 6.15 × 10−8 |
| Ethyl glucuronide | Xenobiotics | Detoxification; chemical | 0.18 | 8.35 × 10−11 |
| α-Hydroxyisovalerate | Amino acid | Valine, leucine/isoleucine | 0.17 | 3.30 × 10−10 |
| Docosapentaenoate (22:5n–3) | Lipid | Essential FA; PUFA (n–3 and n–6) | 0.15 | 9.38 × 10−8 |
| γ-CEHC | C/V | Tocopherol | −0.15 | 3.58 × 10−8 |
| 5α-Androstan-3β,17β-diol disulfate | Lipid | Sterol or steroid | 0.15 | 3.39 × 10−8 |
| Limit solid fats and added sugars | ||||
| 1-Myristoleoylglycerophosphocholine (14:1) | Lipid | Lysolipid | −0.29 | 4.17 × 10−8 |
| cis-4-Decenoyl carnitine | Lipid | Carnitine | 0.27 | <1.00 × 10−16 |
| Linoleoylcarnitine | Lipid | Carnitine | 0.26 | 7.96 × 10−9 |
| Phytanate | Xenobiotics | Food component or plant | −0.26 | 1.53 × 10−9 |
| Linoleate (18:2n–6) | Lipid | Essential FA; PUFA (n–3 and n–6) | 0.25 | <1.00 × 10−16 |
| Myristoyl sphingomyelin | Lipid | Sphingolipid | −0.25 | 2.58 × 10−8 |
| γ-CEHC | C/V | Tocopherol | 0.21 | 1.85 × 10−14 |
| 3-Hydroxy-2-ethylpropionate | Amino acid | Valine, leucine/isoleucine | −0.20 | 6.55 × 10−13 |
| Dihomo-linoleate (20:2n–6) | Lipid | LCFA; PUFA (n–3 and n–6) | 0.19 | 1.51 × 10−12 |
| γ-CEHC glucuronide | C/V | Tocopherol | 0.19 | 1.70 × 10−10 |
| Linolenate (α or γ 18:3n–3 or 18:3n–6) | Lipid | Essential FA; PUFA (n–3 and n–6) | 0.19 | 1.15 × 10−11 |
| 1-Linoleoylglycerol (1-monolinolein) | Lipid | Monoacylglycerol | 0.19 | 9.38 × 10−12 |
| 1-Palmitoleoylglycerophosphoethanolamine | Lipid | Lysolipid | −0.19 | 9.61 × 10−8 |
| Methyl palmitate (15 or 2) | Lipid | FA, branched | −0.18 | 2.06 × 10−11 |
| 1-Linoleoylglycerophosphoinositol | Lipid | Lysolipid | 0.18 | 2.20 × 10−11 |
| 1-Pentadecanoylglycerophosphocholine (15:0) | Lipid | Lysolipid | −0.18 | 1.99 × 10−7 |
| Pentadecanoate (15:0) | Lipid | LCFA | −0.17 | 1.45 × 10−9 |
| 13-Methylmyristic acid | Lipid | FA, branched | −0.17 | 7.81 × 10−9 |
| Caprate (10:0) | Lipid | MCFA | −0.15 | 2.88 × 10−8 |
| Docosadienoate (22:2n–6) | Lipid | LCFA; PUFA (n–3 and n–6) | 0.15 | 7.65 × 10−8 |
| Ergothioneine | Xenobiotics | Food component or plant | 0.15 | 3.43 × 10−8 |
| 17-Methylstearate | Lipid | FA, branched | −0.15 | 4.08 × 10−8 |
n = 1336. Full data (including unidentified metabolites) and metabolite identifying information can be found in the Human Metabolome Database (www.hmdb.ca). Metabolic super- and subpathways, mass, retention index, mass spectrometry platform, and other identifying information can be found in the Supplemental Materials. Carb, carbohydrate; CEHC, carboxyethyl-hydrochroman; C/V, cofactors/vitamins; FA, fatty acid; HEI-2010, Healthy Eating Index 2010; LCFA, long-chain fatty acid; MCFA, medium-chain fatty acid; SAM, S-adenosyl methionine.
Fixed-effects meta-analysis summary estimate from partial Spearman correlation, controlling for age at blood draw (years), BMI, number of years smoked regularly, number of cigarettes smoked per day, daily caloric intake, education (less than elementary or at least elementary), leisure-time physical activity (light to moderate or heavy), and occupational physical activity (nonworking, sedentary, light to moderate, or heavy). Statistically significant with Bonferroni correction for multiple statistical testing at P < 0.05/(1316 metabolites × 36 components) = 1.1 × 10–6).